Journal of International Oncology››2016,Vol. 43››Issue (6): 462-464.doi:10.3760/cma.j.issn.1673-422X.2016.06.017
Previous ArticlesNext Articles
Yan Fei, Yu Shaorong, Cao Haixia, Feng Jifeng
Received:
2015-10-17Online:
2016-06-08Published:
2016-04-27Contact:
Feng Jifeng E-mail:fjif@vip.sina.comSupported by:
Natural Science Foundation of Jiangsu Province of China (BK20141016, BK20141017)
Yan Fei, Yu Shaorong, Cao Haixia, Feng Jifeng. Mechanism of exosome in the pathogenesis of breast cancer[J]. Journal of International Oncology, 2016, 43(6): 462-464.
[1] Lowry MC, Gallagher WM, O′Driscoll L. The role of exosomes in breast cancer[J]. Clin Chem, 2015, 61(12): 1457-1465. DOI: 10.1373/clinchem.2015.240028. [2] Villagrasa A, lvarez PJ, Osuna A, et al. Exosomes derived from breast cancer cells, small trojan horses?[J]. J Mammary Gland Biol Neoplasia, 2014, 19(34): 303-313. DOI: 10.1007/s10911-015-9332-5. [3] Xu R, Greening DW, Rai A, et al. Highlypurified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct[J]. Methods, 2015, 87: 11-25. DOI: 10.1016/j.ymeth.2015.04.008. [4] Sun Y, Liu J. Potential of cancer cellderived exosomes in clinical application: a review of recent research advances[J]. Clin Ther, 2014, 36(6): 863-872. DOI: 10.1016/j.clinthera.2014.04.018. [5] Hsu C, Morohashi Y, Yoshimura S, et al. Regulation of exosome secretion by Rab35 and its GTPaseactivating proteins TBC1D10AC[J]. J Cell Biol, 2010, 189(2): 223-232. DOI: 10.1083/jcb.200911018. [6] Cai Z, Yang F, Yu L, et al. Activated T cell exosomes promote tumor invasion via Fas signaling pathway[J]. J Immunol, 2012, 188(12): 59545961. DOI: 10.4049/jimmunol.1103466. [7] Yuyama K, Sun H, Mitsutake S, et al. Sphingolipidmodulated exosome secretion promotes clearance of amyloidbeta by microglia[J]. J Biol Chem, 2012, 287(14): 10977-10989. DOI: 10.1074/jbc.M111.324616. [8] Ge Q, Zhou Y, Lu J, et al. miRNA in plasma exosome is stable under different storage conditions[J]. Molecules, 2014, 19(2): 1568-1575. DOI: 10.3390/molecules19021568. [9] O′Brien K, Rani S, Corcoran C, et al. Exosomes from triplenegative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells[J]. Eur J Cancer, 2013, 49(8): 1845-1859. DOI: 10.1016/j.ejca.2013.01.017. [10] Tang XJ, Sun XY, Huang KM, et al. Therapeutic potential of CART cellderived exosomes: a cellfree modality for targeted cancer therapy [J]. Oncotarget, 2015, 6(42): 44179-44190. DOI: 10.18632/oncotarget.6175. [11] Ostenfeld MS, Jeppesen DK, Laurberg JR, et al. Cellular disposal of miR23b by RAB27dependent exosome release is linked to acquisition of metastatic properties[J]. Cancer Res, 2014, 74(20): 5758-5771. DOI: 10.1158/00085472.CAN-13-3512. [12] Thompson CA, Purushothaman A, Ramani VC, et al. Heparanase regulates secretion, composition, and function of tumor cellderived exosomes[J]. J Biol Chem, 2013, 288(14): 10093-10099. DOI: 10.1074/jbc.C112.444562. [13] Wang L, Xie Y, Ahmed KA, et al. Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice[J]. Breast Cancer Res Treat, 2013, 140(2): 273-284. DOI: 10.1007/s10549-013-2626-7. [14] Higginbotham JN, Demory Beckler M, Gephart JD, et al. Amphiregulin exosomes increase cancer cell invasion[J]. Curr Biol, 2011, 21(9): 779-786. DOI: 10.1016/j.cub.2011.03.043. [15] Singh R, Pochampally R, Watabe K, et al. Exosomemediated transfer of miR10b promotes cell invasion in breast cancer[J]. Mol Cancer, 2014, 13:256. DOI: 10.1186/1476-4598-13-256. [16] Luga V, Zhang L, ViloriaPetit AM, et al. Exosomes mediate stromal mobilization of autocrine WntPCP signaling in breast cancer cell migration[J]. Cell, 2012, 151(7): 1542-1556. DOI: 10.1016/j.cell.2012.11.024. [17] Zhou W, Fong MY, Min Y, et al. Cancersecreted miR105 destroys vascular endothelial barriers to promote metastasis[J]. Cancer Cell, 2014, 25(4): 501-515. DOI: 10.1016/j.ccr.2014.03.007. [18] Ciravolo V, Huber V, Ghedini GC, et al. Potential role of HER2overexpressing exosomes in countering trastuzumabbased therapy[J]. J Cell Physiol, 2012, 227(2): 658-667. DOI: 10.1002/jcp.22773. [19] Wei Y, Lai X, Yu S, et al. Exosomal miR221/222 enhances tamoxifen resistance in recipient ERpositive breast cancer cells[J]. Breast Cancer Res Treat, 2014, 147(2): 423-431. DOI: 10.1007/s10549-014-3037-0. [20] Zeitzer JM, Nouriani B, Neri E, et al. Correspondence of plasma and salivary cortisol patterns in women with breast cancer[J]. Neuroendocrinology, 2014, 100(23): 153-161. DOI: 10.1159/000367925. [21] Lau CS, Wong DT. Breast cancer exosomelike microvesicles and salivary gland cells interplay alters salivary gland cellderived exosomelike microvesicles in vitro[J]. PLoS One, 2012, 7(3): e33037. DOI: 10.1371/journal.pone.0033037. [22] Khan S, Bennit HF, Turay D, et al. Early diagnostic value of survivin and its alternative splice variants in breast cancer[J]. BMC Cancer, 2014, 14:176. DOI: 10.1186/1471-2407-14-176. |
[1] | Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[2] | Sa Qiang, Xu Hangcheng, Wang Jiayu.Advances in immunotherapy for breast cancer[J]. Journal of International Oncology, 2024, 51(4): 227-234. |
[3] | Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer[J]. Journal of International Oncology, 2024, 51(4): 235-238. |
[4] | Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174. |
[5] | Liu Bohan, Huang Junxing.Research progress of liquid biopsy technology in esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(2): 105-108. |
[6] | Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.Research progress on the histopathological growth patterns of colorectal liver metastasis[J]. Journal of International Oncology, 2024, 51(2): 114-118. |
[7] | Chen Boguang, Wang Sugui, Zhang Yongjie.Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer[J]. Journal of International Oncology, 2024, 51(2): 73-82. |
[8] | Gu Huayan, Zhu Teng, Guo Guilong.Breast microbiota and breast cancer: present and future[J]. Journal of International Oncology, 2024, 51(1): 55-58. |
[9] | Wang Jing, Xu Wenting.Value of NLR, CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm[J]. Journal of International Oncology, 2023, 50(9): 520-526. |
[10] | Feng Chengtian, Huang Furong, Cao Shiyu, Wang Jianyu, Nanding Abiyasi, Jiang Yongdong, Zhu Juanying.Relationships between HER2 protein expression and imaging features in HER2 positive breast cancer patients[J]. Journal of International Oncology, 2023, 50(9): 527-531. |
[11] | Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng.Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway[J]. Journal of International Oncology, 2023, 50(8): 449-456. |
[12] | Pan Shulan, Liu Chang, He Ping.Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer[J]. Journal of International Oncology, 2023, 50(8): 457-462. |
[13] | Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying.Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer[J]. Journal of International Oncology, 2023, 50(8): 475-483. |
[14] | Zhang Yuan, Bai Zhiyu, Li Qi, Feng Qinmei.Current status of research on exosomes in malignancies[J]. Journal of International Oncology, 2023, 50(8): 484-488. |
[15] | Wang Wende, Zeng De.Research progress on the mechanism of endocrine therapy resistance for breast cancer[J]. Journal of International Oncology, 2023, 50(6): 352-356. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||